Skip to Main content Skip to Navigation
Journal articles

Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients

Complete list of metadata

https://hal.univ-reims.fr/hal-03727497
Contributor : laurence Dubois Connect in order to contact the contributor
Submitted on : Tuesday, July 19, 2022 - 12:00:46 PM
Last modification on : Wednesday, July 20, 2022 - 3:37:50 AM

Identifiers

Citation

Georgina Maalouf, Anaïs Andrillon, Mathilde Leclercq, Pascal Sève, Philip Bielefeld, et al.. Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients. American Journal of Ophthalmology, Elsevier Masson, 2022, 238, pp.173-180. ⟨10.1016/j.ajo.2022.02.002⟩. ⟨hal-03727497⟩

Share

Metrics

Record views

0